Effect of kamadeva churna in Oligozoospermia

Effect of Kamadeva churna in Oligozoospermia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053520

Enrollment

Registered

2023-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: with sperm concentration below 20 million per ml

Exclusion criteria

Exclusion criteria: subjects with Aspermia,Azoospermia,with uncontrolled systemic illness.

Design outcomes

Primary

Measure	Time frame
sperm concentrationTimepoint: medicine given for 120days assessment on 0th day and 121st day	—

Secondary

Measure	Time frame
volume pH Viscosity Liquefaction time morphology colour sperm agglutination leukocyte count vitality fructose levelTimepoint: 121st day	—

Countries

India

Contacts

Public ContactDrMaya Balakrishnan

Goverment Ayurveda Medical College and Hospital,Thiruvananthapuram.

bittysunil@gmail.com9961475750

Outcome results